Literature DB >> 19816786

Remarkable differences: the course of life of young adults with galactosaemia and PKU.

A M Bosch1, H Maurice-Stam2, F A Wijburg3, M A Grootenhuis2.   

Abstract

Although the need for insight in factors influencing the quality of life of patients with an inborn error of metabolism is recognized, psychological adjustment of adults with metabolic diseases has not been properly studied. Adult patients with PKU were demonstrated not to differ from healthy controls in terms of their course of life (CoL) and health-related quality of life (HRQoL). However, adults with galactosaemia had a lower HRQoL with significant lower scores on the domains of cognitive and social function. This study investigated the CoL and the social demographical outcomes in these young adults with galactosaemia, and compared them with the general population and with PKU patients. A total of 15 (88%) adult patients with classical galactosaemia participated in this study. Classical galactosaemia patients had a delayed social and psychosexual development compared to their peers from the general population and to PKU patients. Also, they were significantly less frequently married or living together and significantly less frequently employed than the general population. Our study shows a stark contrast between patients with galactosaemia and patients with PKU, although both are diagnosed in the neonatal period and need life-long dietary restrictions. The observed difference is likely due to the long-term somatic complications frequently seen in galactosaemia and thus not due to the burden of a chronic disease necessitating life-long dietary restrictions. We conclude that it is essential that parents and clinicians encourage children with galactosaemia to participate in peer-related activities in order to stimulate social performance, which may result in a more normal CoL.

Entities:  

Mesh:

Year:  2009        PMID: 19816786     DOI: 10.1007/s10545-009-1253-2

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  11 in total

1.  The course of life of survivors of childhood cancer.

Authors:  H Stam; M A Grootenhuis; B F Last
Journal:  Psychooncology       Date:  2005-03       Impact factor: 3.894

2.  Long-term prognosis in galactosaemia: results of a survey of 350 cases.

Authors:  D D Waggoner; N R Buist; G N Donnell
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  Cognitive functions in classic phenylketonuria and mild hyperphenylalaninaemia: experience in a paediatric population.

Authors:  Rosa Gassió; Rafael Artuch; Maria Antonia Vilaseca; Eugenia Fusté; Cristina Boix; Anna Sans; Jaume Campistol
Journal:  Dev Med Child Neurol       Date:  2005-07       Impact factor: 5.449

4.  Adjustment and intelligence among children with phenylketonuria in Sweden.

Authors:  G Lundstedt; A Johansson; L Melin; J Alm
Journal:  Acta Paediatr       Date:  2001-10       Impact factor: 2.299

5.  The impact of galactosaemia on quality of life--a pilot study.

Authors:  C Lambert; A Boneh
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

6.  Identification of novel mutations in classical galactosemia.

Authors:  Annet M Bosch; Lodewijk Ijlst; Wendy Oostheim; Joyce Mulders; Henk D Bakker; Frits A Wijburg; Ronald J A Wanders; Hans R Waterham
Journal:  Hum Mutat       Date:  2005-05       Impact factor: 4.878

7.  The course of life and quality of life of early and continuously treated Dutch patients with phenylketonuria.

Authors:  A M Bosch; W Tybout; F J van Spronsen; H W de Valk; F A Wijburg; M A Grootenhuis
Journal:  J Inherit Metab Dis       Date:  2006-12-11       Impact factor: 4.982

8.  Classification of childhood psychopathology: a developmental perspective.

Authors:  J Garber
Journal:  Child Dev       Date:  1984-02

9.  Psychological and social findings in adolescents with phenylketonuria.

Authors:  J Weglage; B Fünders; B Wilken; D Schubert; E Schmidt; P Burgard; K Ullrich
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

10.  Long-term outcome in 134 patients with galactosaemia.

Authors:  S Schweitzer; Y Shin; C Jakobs; J Brodehl
Journal:  Eur J Pediatr       Date:  1993-01       Impact factor: 3.183

View more
  16 in total

1.  Introduction to the Maastricht workshop: lessons from the past and new directions in galactosemia.

Authors:  Gerard T Berry; Louis J Elsas
Journal:  J Inherit Metab Dis       Date:  2010-11-30       Impact factor: 4.982

2.  Living situation, occupation and health-related quality of life in adult patients with classic galactosemia.

Authors:  Björn Hoffmann; Nico Dragano; Susanne Schweitzer-Krantz
Journal:  J Inherit Metab Dis       Date:  2012-03-24       Impact factor: 4.982

3.  Novel mRNA-Based Therapy Reduces Toxic Galactose Metabolites and Overcomes Galactose Sensitivity in a Mouse Model of Classic Galactosemia.

Authors:  Bijina Balakrishnan; Ding An; Vi Nguyen; Christine DeAntonis; Paolo G V Martini; Kent Lai
Journal:  Mol Ther       Date:  2019-09-19       Impact factor: 11.454

4.  Diversity of approaches to classic galactosemia around the world: a comparison of diagnosis, intervention, and outcomes.

Authors:  Patricia P Jumbo-Lucioni; Kathryn Garber; John Kiel; Ivo Baric; Gerard T Berry; Annet Bosch; Alberto Burlina; Ana Chiesa; Maria Luz Couce Pico; Sylvia C Estrada; Howard Henderson; Nancy Leslie; Nicola Longo; Andrew A M Morris; Carlett Ramirez-Farias; Susanne Schweitzer-Krantz; Susanne Scheweitzer-Krantz; Catherine Lynn T Silao; Marcela Vela-Amieva; Susan Waisbren; Judith L Fridovich-Keil
Journal:  J Inherit Metab Dis       Date:  2012-03-27       Impact factor: 4.982

5.  Friedreich Ataxia in Classical Galactosaemia.

Authors:  Siobhán Neville; Siobhan O'Sullivan; Bronagh Sweeney; Bryan Lynch; Donncha Hanrahan; Ina Knerr; Sally Ann Lynch; Ellen Crushell
Journal:  JIMD Rep       Date:  2015-07-29

6.  Classic galactosemia: dietary dilemmas.

Authors:  Annet M Bosch
Journal:  J Inherit Metab Dis       Date:  2010-07-13       Impact factor: 4.982

7.  Psychosocial developmental milestones in men with classic galactosemia.

Authors:  Cynthia Sophia Gubbels; Heleen Maurice-Stam; Gerard Thomas Berry; Annet Maria Bosch; Susan Waisbren; Maria Estela Rubio-Gozalbo; Martha Alexandra Grootenhuis
Journal:  J Inherit Metab Dis       Date:  2011-02-25       Impact factor: 4.982

8.  Neuroradiologic Phenotyping of Galactosemia: From the Neonatal Form to the Chronic Stage.

Authors:  M C Rossi-Espagnet; S Sudhakar; E Fontana; D Longo; J Davison; A L Petengill; E Bevivino; F T Pacheco; A J da Rocha; P Hanagandi; M Soldatelli; K Mankad; L L F do Amaral
Journal:  AJNR Am J Neuroradiol       Date:  2021-01-21       Impact factor: 3.825

9.  Longitudinal quality of life analysis in a phenylketonuria cohort provided sapropterin dihydrochloride.

Authors:  Teresa D Douglas; Usha Ramakrishnan; Julie A Kable; Rani H Singh
Journal:  Health Qual Life Outcomes       Date:  2013-12-30       Impact factor: 3.186

Review 10.  Fertility preservation in female classic galactosemia patients.

Authors:  Britt van Erven; Cynthia S Gubbels; Ron J van Golde; Gerard A Dunselman; Josien G Derhaag; Guido de Wert; Joep P Geraedts; Annet M Bosch; Eileen P Treacy; Corrine K Welt; Gerard T Berry; M Estela Rubio-Gozalbo
Journal:  Orphanet J Rare Dis       Date:  2013-07-16       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.